These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 24289229)

  • 1. Breast cancers with high DSS1 expression that potentially maintains BRCA2 stability have poor prognosis in the relapse-free survival.
    Rezano A; Kuwahara K; Yamamoto-Ibusuki M; Kitabatake M; Moolthiya P; Phimsen S; Suda T; Tone S; Yamamoto Y; Iwase H; Sakaguchi N
    BMC Cancer; 2013 Dec; 13():562. PubMed ID: 24289229
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Increased chemosensitivity via BRCA2-independent DNA damage in DSS1- and PCID2-depleted breast carcinomas.
    Gondo N; Sakai Y; Zhang Z; Hato Y; Kuzushima K; Phimsen S; Kawashima Y; Kuroda M; Suzuki M; Okada S; Iwata H; Toyama T; Rezano A; Kuwahara K
    Lab Invest; 2021 Aug; 101(8):1048-1059. PubMed ID: 34031538
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DSS1 is required for the stability of BRCA2.
    Li J; Zou C; Bai Y; Wazer DE; Band V; Gao Q
    Oncogene; 2006 Feb; 25(8):1186-94. PubMed ID: 16205630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Interaction between the product of the breast cancer susceptibility gene BRCA2 and DSS1, a protein functionally conserved from yeast to mammals.
    Marston NJ; Richards WJ; Hughes D; Bertwistle D; Marshall CJ; Ashworth A
    Mol Cell Biol; 1999 Jul; 19(7):4633-42. PubMed ID: 10373512
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Promotion of BRCA2-Dependent Homologous Recombination by DSS1 via RPA Targeting and DNA Mimicry.
    Zhao W; Vaithiyalingam S; San Filippo J; Maranon DG; Jimenez-Sainz J; Fontenay GV; Kwon Y; Leung SG; Lu L; Jensen RB; Chazin WJ; Wiese C; Sung P
    Mol Cell; 2015 Jul; 59(2):176-87. PubMed ID: 26145171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Role of MRE11 in cell proliferation, tumor invasion, and DNA repair in breast cancer.
    Yuan SS; Hou MF; Hsieh YC; Huang CY; Lee YC; Chen YJ; Lo S
    J Natl Cancer Inst; 2012 Oct; 104(19):1485-502. PubMed ID: 22914783
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Increased ID4 expression, accompanied by mutant p53 accumulation and loss of BRCA1/2 proteins in triple-negative breast cancer, adversely affects survival.
    Thike AA; Tan PH; Ikeda M; Iqbal J
    Histopathology; 2016 Apr; 68(5):702-12. PubMed ID: 26259780
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of BRCA2 gene in sporadic breast tumours.
    Bièche I; Noguès C; Lidereau R
    Oncogene; 1999 Sep; 18(37):5232-8. PubMed ID: 10498873
    [TBL] [Abstract][Full Text] [Related]  

  • 9. DSS1 is required for RAD51 focus formation and genomic stability in mammalian cells.
    Gudmundsdottir K; Lord CJ; Witt E; Tutt AN; Ashworth A
    EMBO Rep; 2004 Oct; 5(10):989-93. PubMed ID: 15359272
    [TBL] [Abstract][Full Text] [Related]  

  • 10. MicroRNA-101 Suppresses Tumor Cell Proliferation by Acting as an Endogenous Proteasome Inhibitor via Targeting the Proteasome Assembly Factor POMP.
    Zhang X; Schulz R; Edmunds S; Krüger E; Markert E; Gaedcke J; Cormet-Boyaka E; Ghadimi M; Beissbarth T; Levine AJ; Moll UM; Dobbelstein M
    Mol Cell; 2015 Jul; 59(2):243-57. PubMed ID: 26145175
    [TBL] [Abstract][Full Text] [Related]  

  • 11. High expression and prognostic role of CAP1 and CtBP2 in breast carcinoma: associated with E-cadherin and cell proliferation.
    Liu X; Yao N; Qian J; Huang H
    Med Oncol; 2014 Mar; 31(3):878. PubMed ID: 24522810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Annexin A3 is associated with a poor prognosis in breast cancer and participates in the modulation of apoptosis in vitro by affecting the Bcl-2/Bax balance.
    Zeng C; Ke Z; Song Y; Yao Y; Hu X; Zhang M; Li H; Yin J
    Exp Mol Pathol; 2013 Aug; 95(1):23-31. PubMed ID: 23631820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Silencing RBBP6 (Retinoblastoma Binding Protein 6) sensitises breast cancer cells MCF7 to staurosporine and camptothecin-induced cell death.
    Moela P; Choene MM; Motadi LR
    Immunobiology; 2014 Aug; 219(8):593-601. PubMed ID: 24703106
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prognostic value of phosphorylated HER2 in HER2-positive breast cancer patients treated with adjuvant trastuzumab.
    Kurebayashi J; Kanomata N; Yamashita T; Shimo T; Mizutoh A; Moriya T; Sonoo H
    Breast Cancer; 2015 May; 22(3):292-9. PubMed ID: 23749689
    [TBL] [Abstract][Full Text] [Related]  

  • 15. p14ARF expression in invasive breast cancers and ductal carcinoma in situ--relationships to p53 and Hdm2.
    Vestey SB; Sen C; Calder CJ; Perks CM; Pignatelli M; Winters ZE
    Breast Cancer Res; 2004; 6(5):R571-85. PubMed ID: 15318938
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Elevated nuclear S100P expression is associated with poor survival in early breast cancer patients.
    Maciejczyk A; Łacko A; Ekiert M; Jagoda E; Wysocka T; Matkowski R; Hałoń A; Györffy B; Lage H; Surowiak P
    Histol Histopathol; 2013 Apr; 28(4):513-24. PubMed ID: 23364898
    [TBL] [Abstract][Full Text] [Related]  

  • 17. PSMB4 overexpression enhances the cell growth and viability of breast cancer cells leading to a poor prognosis.
    Wang H; He Z; Xia L; Zhang W; Xu L; Yue X; Ru X; Xu Y
    Oncol Rep; 2018 Oct; 40(4):2343-2352. PubMed ID: 30066880
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Upregulation of p21WAF1/CIP1 in human breast cancer cell lines MCF-7 and MDA-MB-468 undergoing apoptosis induced by natural product anticancer drugs 10-hydroxycamptothecin and camptothecin through p53-dependent and independent pathways.
    Liu W; Zhang R
    Int J Oncol; 1998 Apr; 12(4):793-804. PubMed ID: 9499438
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Expression and prognostic role of SKIP in human breast carcinoma.
    Liu X; Ni Q; Xu J; Sheng C; Wang Q; Chen J; Yang S; Wang H
    J Mol Histol; 2014 Apr; 45(2):169-80. PubMed ID: 24150787
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Involvement of p53 in insulin-like growth factor binding protein-3 regulation in the breast cancer cell response to DNA damage.
    Marzec KA; Lin MZ; Martin JL; Baxter RC
    Oncotarget; 2015 Sep; 6(29):26583-98. PubMed ID: 26378048
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.